IMMP
NASDAQ
$0.41
Immutep Ltd (IMMP)
Immutep Limited, a biotechnology company, is dedicated to the research and development of pharmaceutical candidates. The company is headquartered in Sydney, Australia.
Sector:
Healthcare
Industry:
Biotechnology
Hold
Target: $1.50 (+268.01%)
Market Cap
$64M
P/B Ratio
0.94
EPS 5Y CAGR
+20.94%
FCF 5Y CAGR
+28.35%
Price Chart
Valuation
Market Cap$64M
Forward P/E7.13
P/S8.12
P/B0.94
Profitability
Total Revenue (TTM)$8.54M
Gross Profit (TTM)-$50M
EBITDA-$87M
Operating Margin-764%
EPS-$0.60
Financial Health
Debt-to-Equity1.2%
Free Cash Flow Yield-63.72%
Growth & Risk
EPS 5Y CAGR+20.94%
Revenue 5Y CAGR+3.96%
FCF 5Y CAGR+28.35%
Beta (5Y)0.80
Sharpe Ratio-0.13